| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |